Innovative Therapies and Tools for Screenable Disorders in Newborns (R21)

The summary for the Innovative Therapies and Tools for Screenable Disorders in Newborns (R21) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


Federal Grant Title: Innovative Therapies and Tools for Screenable Disorders in Newborns (R21)
CFDA Number: 93.173
CFDA Description: Research Related to Deafness and Communication Disorders
Federal Agency Name: National Institutes of Health
Category of Funding Activity: Food and Nutrition Health Income Security and Social Services
Category Explanation: Information not provided
Opportunity Category: Discretionary
Funding Opportunity Number: PAR-10-232
Document Type: Grants Notice
Funding Instrument Type: Grant
Posted Date: Jul 19, 2010
Creation Date: Jul 19, 2010
Original Closing Date for Applications: Sep 16, 2013
Current Closing Date for Applications: Sep 16, 2013
Archive Date: Oct 17, 2013
Expected Number of Awards: Information not provided
Estimated Total Program Funding: Information not provided
Federal Grant Award Ceiling: $200,000
Federal Grant Award Floor: Information not provided
Cost Sharing or Matching Requirement: No

Applicants Eligible for this Grant
State governments - County governments - City or township governments - Special district governments - Independent school districts - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Public housing authorities/Indian housing authorities - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Grant Description
Purpose. This Funding Opportunity Announcement (FOA) issued by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), the National Institute of Diabetes and Digestive and Kidney Disease (NIDDK) and National Institute on Deafness and Other Communication Disorders (NIDCD) encourages Research Project Grant (R21) applications from institutions/ organizations that propose research relevant to the basic understanding and development of therapeutic interventions for currently screened conditions and high priority genetic conditions for which screening could be possible in the near future. In this FOA, a high priority condition is one for which the development of an efficacious therapy would make the condition amenable to newborn screening. Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with two FOAs of identical scientific scope, PAR-10-230 and PAR-10-231, that encourage applications under the R01 and R03 mechanisms. Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/pa-files/par-10-232.html
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Psychosocial/Behavioral Interventions and Services Research in Autism Spectrum Disorders (R34)
NIDCD Research On Hearing Health Care (R21/R33)
Lab to Marketplace: Tools for Brain and Behavioral Research (SBIR [R43/R44])
Reducing Health Disparities Among Minority and Underserved Children (R21)
Reducing Health Disparities Among Minority and Underserved Children (R01)
NIDCD Patient-Oriented Research Grant (R21)
CELL LINEAGE AND DEVELOPMENTAL STUDIES IN HEARING AND BALANCE
Structural Analyses of the Ligand-Binding Properties of Taste and Smell Receptors
NIDCD Patient-Oriented Research Grant
NIDCD SMALL GRANT (R03) PROGRAM

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2012 FederalGrants.com